Search Results - "Schoen, Robert E"

Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years by Ladabaum, Uri, Mannalithara, Ajitha, Meester, Reinier G.S., Gupta, Samir, Schoen, Robert E.

“…The American Cancer Society has recommended initiating colorectal cancer (CRC) screening at age 45 years instead of 50 years. We estimated the cost…”
Get full text

World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer by Rutter, Matthew D., Beintaris, Iosif, Valori, Roland, Chiu, Han Mo, Corley, Douglas A., Cuatrecasas, Miriam, Dekker, Evelien, Forsberg, Anna, Gore-Booth, Jola, Haug, Ulrike, Kaminski, Michal F., Matsuda, Takahisa, Meijer, Gerrit A., Morris, Eva, Plumb, Andrew A., Rabeneck, Linda, Robertson, Douglas J., Schoen, Robert E., Singh, Harminder, Tinmouth, Jill, Young, Graeme P., Sanduleanu, Silvia

“…Colonoscopy examination does not always detect colorectal cancer (CRC)— some patients develop CRC after negative findings from an examination. When this occurs…”
Get full text

Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer by Ma, Peiwen, Beatty, Pamela L, McKolanis, John, Brand, Randal, Schoen, Robert E, Finn, Olivera J

“…Myeloid derived suppressor cells (MDSC) are a heterogeneous population of immature myeloid cells that accumulate in circulation of cancer patients and at tumor…”
Get full text

Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors by Jeon, Jihyoun, Du, Mengmeng, Schoen, Robert E., Hoffmeister, Michael, Newcomb, Polly A., Berndt, Sonja I., Caan, Bette, Campbell, Peter T., Chan, Andrew T., Chang-Claude, Jenny, Giles, Graham G., Gong, Jian, Harrison, Tabitha A., Huyghe, Jeroen R., Jacobs, Eric J., Li, Li, Lin, Yi, Le Marchand, Loïc, Potter, John D., Qu, Conghui, Bien, Stephanie A., Zubair, Niha, Macinnis, Robert J., Buchanan, Daniel D., Hopper, John L., Cao, Yin, Nishihara, Reiko, Rennert, Gad, Slattery, Martha L., Thomas, Duncan C., Woods, Michael O., Prentice, Ross L., Gruber, Stephen B., Zheng, Yingye, Brenner, Hermann, Hayes, Richard B., White, Emily, Peters, Ulrike, Hsu, Li

“…Guidelines for initiating colorectal cancer (CRC) screening are based on family history but do not consider lifestyle, environmental, or genetic risk factors…”
Get full text

PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice by Qiu, Wei, Wu, Bin, Wang, Xinwei, Buchanan, Monica E, Regueiro, Miguel D, Hartman, Douglas J, Schoen, Robert E, Yu, Jian, Zhang, Lin

“…Intestinal epithelial cell (IEC) apoptosis contributes to the development of ulcerative colitis (UC), an inflammatory bowel disease (IBD) that affects the…”
Get full text

Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum by Brennan, Caitlin A, Nakatsu, Geicho, Gallini Comeau, Carey Ann, Drew, David A, Glickman, Jonathan N, Schoen, Robert E, Chan, Andrew T, Garrett, Wendy S

“…Aspirin is a chemopreventive agent for colorectal adenoma and cancer (CRC) that, like many drugs inclusive of chemotherapeutics, has been investigated for its…”
Get full text

A Model to Determine Colorectal Cancer Risk Using Common Genetic Susceptibility Loci by Hsu, Li, Jeon, Jihyoun, Brenner, Hermann, Gruber, Stephen B, Schoen, Robert E, Berndt, Sonja I, Chan, Andrew T, Chang-Claude, Jenny, Du, Mengmeng, Gong, Jian, Harrison, Tabitha A, Hayes, Richard B, Hoffmeister, Michael, Hutter, Carolyn M, Lin, Yi, Nishihara, Reiko, Ogino, Shuji, Prentice, Ross L, Schumacher, Fredrick R, Seminara, Daniela, Slattery, Martha L, Thomas, Duncan C, Thornquist, Mark, Newcomb, Polly A, Potter, John D, Zheng, Yingye, White, Emily, Peters, Ulrike

“…Background & Aims Risk for colorectal cancer (CRC) can be greatly reduced through screening. To aid in the development of screening strategies, we refined…”
Get full text

Estimating the heritability of colorectal cancer by Jiao, Shuo, Peters, Ulrike, Berndt, Sonja, Brenner, Hermann, Butterbach, Katja, Caan, Bette J, Carlson, Christopher S, Chan, Andrew T, Chang-Claude, Jenny, Chanock, Stephen, Curtis, Keith R, Duggan, David, Gong, Jian, Harrison, Tabitha A, Hayes, Richard B, Henderson, Brian E, Hoffmeister, Michael, Kolonel, Laurence N, Le Marchand, Loic, Potter, John D, Rudolph, Anja, Schoen, Robert E, Seminara, Daniela, Slattery, Martha L, White, Emily, Hsu, Li

“…A sizable fraction of colorectal cancer (CRC) is expected to be explained by heritable factors, with heritability estimates ranging from 12 to 35% twin and…”
Get full text

Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study by Leung, Keith, MD, Pinsky, Paul, PhD, Laiyemo, Adeyinka O., MD, MPH, Lanza, Elaine, PhD, Schatzkin, Arthur, MD, DrPH, Schoen, Robert E., MD, MPH

“…Background Despite regular colonoscopy, interval colorectal cancer (CRC) may occur. Long-term studies examining CRC rates in patients with previous colonoscopy…”
Get full text

Pre-vaccination transcriptomic profiles of immune responders to the MUC1 peptide vaccine for colon cancer prevention by Cameron, Cheryl M, Raghu, Vineet, Richardson, Brian, Zagore, Leah L, Tamilselvan, Banumathi, Golden, Jackelyn, Cartwright, Michael, Schoen, Robert E, Finn, Olivera J, Benos, Panayiotis V, Cameron, Mark J

“…Self-antigens abnormally expressed on tumors, such as MUC1, have been targeted by therapeutic cancer vaccines. We recently assessed in two clinical trials in a…”
Get full text

Influence of Smoking, Body Mass Index, and Other Factors on the Preventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Colorectal Cancer Risk by Wang, Xiaoliang, Chan, Andrew T, Slattery, Martha L, Chang-Claude, Jenny, Potter, John D, Gallinger, Steven, Caan, Bette, Lampe, Johanna W, Newcomb, Polly A, Zubair, Niha, Hsu, Li, Schoen, Robert E, Hoffmeister, Michael, Brenner, Hermann, Le Marchand, Loic, Peters, Ulrike, White, Emily

“…Nonsteroidal anti-inflammatory drugs' (NSAID) use has consistently been associated with lower risk of colorectal cancer; however, studies showed inconsistent…”
Get full text

Strategies for Colorectal Cancer Screening by Ladabaum, Uri, Dominitz, Jason A., Kahi, Charles, Schoen, Robert E.

“…The incidence of colorectal cancer (CRC) is increasing worldwide. CRC has high mortality when detected at advanced stages, yet it is also highly preventable…”
Get full text

Prospective and Mendelian randomization analyses on the association of circulating fatty acid binding protein 4 (FABP-4) and risk of colorectal cancer by Nimptsch, Katharina, Aleksandrova, Krasimira, Pham, Thu Thi, Papadimitriou, Nikos, Janke, Jürgen, Christakoudi, Sofia, Heath, Alicia, Olsen, Anja, Tjønneland, Anne, Schulze, Matthias B, Katzke, Verena, Kaaks, Rudolf, van Guelpen, Bethany, Harbs, Justin, Palli, Domenico, Macciotta, Alessandra, Pasanisi, Fabrizio, Yohar, Sandra Milena Colorado, Guevara, Marcela, Amiano, Pilar, Grioni, Sara, Jakszyn, Paula Gabriela, Figueiredo, Jane C, Samadder, N Jewel, Li, Christopher I, Moreno, Victor, Potter, John D, Schoen, Robert E, Um, Caroline Y, Weiderpass, Elisabete, Jenab, Mazda, Gunter, Marc J, Pischon, Tobias

“…Fatty acid binding protein 4 (FABP-4) is a lipid-binding adipokine upregulated in obesity, which may facilitate fatty acid supply for tumor growth and promote…”
Get full text

Public reporting of colonoscopy quality is associated with an increase in endoscopist adenoma detection rate by Abdul-Baki, Heitham, MD, Schoen, Robert E., MD, MPH, Dean, Katie, Rose, Sherri, PhD, Leffler, Daniel A., MD, Kuganeswaran, Eliathamby, MD, Morris, Michele, Carrell, David, PhD, Mehrotra, Ateev, MD

“…Background Colonoscopy is the predominant method for colorectal cancer screening in the United States. Previous studies have documented variation across…”
Get full text

Prospective Investigation of Body Mass Index, Colorectal Adenoma, and Colorectal Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial by KITAHARA, Cari M, BERNDT, Sonja I, DE GONZALEZ, Amy Berrington, COLEMAN, Helen G, SCHOEN, Robert E, HAYES, Richard B, HUANG, Wen-Yi

“…Obesity has consistently been linked to an increased risk of colorectal cancer, particularly among men. Whether body mass index (BMI) differentially influences…”
Get full text

Adenoma Detection Rate Falls at the End of the Day in a Large Multi-site Sample by Marcondes, Felippe O., Gourevitch, Rebecca A., Schoen, Robert E., Crockett, Seth D., Morris, Michele, Mehrotra, Ateev

“…Background There is concern that mental and physical fatigue among endoscopists over the course of the day will lead to lower adenoma detection rate (ADR)…”
Get full text

eIF4E S209 phosphorylation licenses myc- and stress-driven oncogenesis by Ruan, Hang, Li, Xiangyun, Xu, Xiang, Leibowitz, Brian J, Tong, Jingshan, Chen, Lujia, Ao, Luoquan, Xing, Wei, Luo, Jianhua, Yu, Yanping, Schoen, Robert E, Sonenberg, Nahum, Lu, Xinghua, Zhang, Lin, Yu, Jian

“…To better understand a role of eIF4E S209 in oncogenic translation, we generated heterozygous knockin (4EKI) HCT 116 human colorectal cancer (CRC) cells. 4EKI…”
Get full text

Enrollee characteristics and receipt of colorectal cancer testing in Pennsylvania after adoption of the Affordable Care Act Medicaid expansion by Eom, Kirsten Y., Rothenberger, Scott D., Jarlenski, Marian P., Schoen, Robert E., Cole, Evan S., Sabik, Lindsay M.

“…Background Colorectal cancer (CRC) is the fourth most common cancer and the second leading cause of cancer‐related death in the U.S. Despite increased CRC…”
Get full text

Applying a natural language processing tool to electronic health records to assess performance on colonoscopy quality measures by Mehrotra, Ateev, MD, MPH, Dellon, Evan S., MD, MPH, Schoen, Robert E., MD, MPH, Saul, Melissa, MS, Bishehsari, Faraz, MD, PhD, Farmer, Carrie, PhD, Harkema, Henk, PhD

“…Background Gastroenterology specialty societies have advocated that providers routinely assess their performance on colonoscopy quality measures. Such routine…”
Get full text

Chemoprevention by nonsteroidal anti-inflammatory drugs eliminates oncogenic intestinal stem cells via SMAC-dependent apoptosis by Qiu, Wei, Wang, Xinwei, Leibowitz, Brian, Liu, Hongtao, Barker, Nick, Okada, Hitoshi, Oue, Naohide, Yasui, Wataru, Clevers, Hans, Schoen, Robert E., Yu, Jian, Zhang, Lin, Vogelstein, Bert

“…Nonsteroidal anti-inflammatory drugs (NSAIDs) such as sulindac effectively prevent colon cancer in humans and rodent models. However, their cellular targets…”
Get full text